Company profile ADIL
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Adial Pharmaceuticals expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 91 | 63 -30.8% QoQ | 110 74.6% QoQ | 188 70.9% QoQ |
| 2020 | 174 91.2% YoY -7.4% QoQ | 311 393.7% YoY 78.7% QoQ | 242 120.0% YoY -22.2% QoQ | 58 -69.1% YoY -76.0% QoQ |
| 2021 | 126 -27.6% YoY 117.2% QoQ | 188 -39.5% YoY 49.2% QoQ | 65 -73.1% YoY -65.4% QoQ | 25 -56.9% YoY -61.5% QoQ |
| 2022 | 80 -36.5% YoY 220.0% QoQ | 32 -83.0% YoY -60.0% QoQ | 367 464.6% YoY 1046.9% QoQ | 83 232.0% YoY -77.4% QoQ |
| 2023 | 181 126.2% YoY 118.1% QoQ | 161 403.1% YoY -11.0% QoQ | 56 -84.7% YoY -65.2% QoQ | 349 320.5% YoY 523.2% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Adial Pharmaceuticals was 11.3 per week. The last year interest of Adial Pharmaceuticals compared to the last 5 years has changed by 15.04%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 40.24%.
There is not enough data for AD04 clinical trial to provide analysis
There is not enough data for AD04 clinical trial to provide correlation calculation
There is not enough data for AD04 clinical trial to provide analysis
After 39 days of this quarter the interest is at 189.0. Based on that we can calculate that during remaining 52 days it will total up to 441.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 199 | 189 -5.0% QoQ | 125 -33.9% QoQ | 201 60.8% QoQ |
| 2020 | 187 -6.0% YoY -7.0% QoQ | 286 51.3% YoY 52.9% QoQ | 263 110.4% YoY -8.0% QoQ | 404 101.0% YoY 53.6% QoQ |
| 2021 | 268 43.3% YoY -33.7% QoQ | 336 17.5% YoY 25.4% QoQ | 217 -17.5% YoY -35.4% QoQ | 338 -16.3% YoY 55.8% QoQ |
| 2022 | 440 64.2% YoY 30.2% QoQ | 491 46.1% YoY 11.6% QoQ | 367 69.1% YoY -25.3% QoQ | 518 53.3% YoY 41.1% QoQ |
| 2023 | 469 6.6% YoY -9.5% QoQ | 534 8.8% YoY 13.9% QoQ | 421 14.7% YoY -21.2% QoQ | 711 37.3% YoY 68.9% QoQ |
| 2024 | 189 -59.7% YoY -73.4% QoQ | - | - | - |
The average 5 years interest of Alcohol use disorder treatment was 27.41 per week. The last year interest of Alcohol use disorder treatment compared to the last 5 years has changed by 51.33%. The interest for Alcohol use disorder treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 176.17%.
There is not enough data for Non-opioid pain reduction to provide analysis
There is not enough data for Non-opioid pain reduction to provide correlation calculation
There is not enough data for Non-opioid pain reduction to provide analysis
After 39 days of this quarter the interest is at 30.0. Based on that we can calculate that during remaining 52 days it will total up to 70.0. Adial Pharmaceuticals stock expected interest is significantly lower compared to previous quarter (-54.2%) and same quarter last year (-62.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 152 inf% QoQ | 36 -76.3% QoQ | 68 88.9% QoQ |
| 2020 | 54 inf% YoY -20.6% QoQ | 161 5.9% YoY 198.1% QoQ | 81 125.0% YoY -49.7% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 65 20.4% YoY inf% QoQ | 206 28.0% YoY 216.9% QoQ | 190 134.6% YoY -7.8% QoQ | 174 inf% YoY -8.4% QoQ |
| 2022 | 19 -70.8% YoY -89.1% QoQ | 27 -86.9% YoY 42.1% QoQ | 87 -54.2% YoY 222.2% QoQ | 105 -39.7% YoY 20.7% QoQ |
| 2023 | 186 878.9% YoY 77.1% QoQ | 153 466.7% YoY -17.7% QoQ | 71 -18.4% YoY -53.6% QoQ | 153 45.7% YoY 115.5% QoQ |
| 2024 | 30 -83.9% YoY -80.4% QoQ | - | - | - |
The average 5 years interest of Adial Pharmaceuticals stock was 7.73 per week. The last year interest of Adial Pharmaceuticals stock compared to the last 5 years has changed by 37.39%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 115.85%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Adial Pharmaceuticals news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 41 | 82 100.0% QoQ | 78 -4.9% QoQ | 79 1.3% QoQ |
| 2020 | 0 -100.0% YoY -100.0% QoQ | 138 68.3% YoY inf% QoQ | 195 150.0% YoY 41.3% QoQ | 233 194.9% YoY 19.5% QoQ |
| 2021 | 113 inf% YoY -51.5% QoQ | 169 22.5% YoY 49.6% QoQ | 88 -54.9% YoY -47.9% QoQ | 86 -63.1% YoY -2.3% QoQ |
| 2022 | 100 -11.5% YoY 16.3% QoQ | 37 -78.1% YoY -63.0% QoQ | 167 89.8% YoY 351.4% QoQ | 18 -79.1% YoY -89.2% QoQ |
| 2023 | 71 -29.0% YoY 294.4% QoQ | 56 51.4% YoY -21.1% QoQ | 57 -65.9% YoY 1.8% QoQ | 27 50.0% YoY -52.6% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Adial Pharmaceuticals news was 7.03 per week. The last year interest of Adial Pharmaceuticals news compared to the last 5 years has changed by -42.25%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -24.54%.
There is not enough data for Adial Pharmaceuticals careers to provide analysis
There is not enough data for Adial Pharmaceuticals careers to provide correlation calculation
There is not enough data for Adial Pharmaceuticals careers to provide analysis
There is not enough data for Adial Pharmaceuticals reviews to provide analysis
There is not enough data for Adial Pharmaceuticals reviews to provide correlation calculation
There is not enough data for Adial Pharmaceuticals reviews to provide analysis
There is not enough data for Adial Pharmaceuticals Virginia to provide analysis
There is not enough data for Adial Pharmaceuticals Virginia to provide correlation calculation
There is not enough data for Adial Pharmaceuticals Virginia to provide analysis
There is not enough data for Adial Pharmaceuticals -stock -company to provide analysis
There is not enough data for Adial Pharmaceuticals -stock -company to provide correlation calculation
There is not enough data for Adial Pharmaceuticals -stock -company to provide analysis